Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose urokinase for progressive ischemic stroke
ChiCTR2100046384Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Apr 2021
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of urokinase in ischemic stroke (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: NIH Stroke Scale, Brain CT / MRI and 1 more. Started Apr 2021; status: recruiting.
02
Drugs
urokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100046384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046384.